NRIX
Nurix Therapeutics, Inc.
$15.60−0.73 (−4.47%)Close Nov 12, 2026
Jul 24, 2020 – Nov 12, 2026, Dividends reinvested
- Final balance
- $8,206
- CAGR
- −3.09%
- Max drawdown
- −91.53%
- Sharpe ratio
- 0.36
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
NRIX's average annual return was −14.46% over the last 5 years, through Nov 12, 2026. $10,000 in NRIX on Nov 12, 2021 fell to $4,580 by Nov 12, 2026, with dividends reinvested.
Total
- 1M
- −29.60%
- 3M
- −41.42%
- 6M
- −2.26%
- YTD
- −17.76%
- 1Y
- +28.18%
Per year
- 3Y
- +43.58%
- 5Y
- −14.46%
- Since 2020
- −3.09%
Annual returns
2020 from Jul 24 · 2026 through Nov 12
NRIX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 12 | −17.76% |
| 2025 | +0.69% |
| 2024 | +82.56% |
| 2023 | −6.01% |
| 2022 | −62.07% |
| 2021 | −11.95% |
| 2020 from Jul 24 | +72.96% |
Metrics
Since 2020| Volatility | 79.69% |
|---|---|
| Sortino ratio | 0.54 |
| Calmar ratio | −0.03 |
| Best year, 2024 | +82.56% |
| Worst year, 2022 | −62.07% |
| Positive years | 2 of 5 |
| Longest drawdown | 5.8 years |
Worst drawdowns
Since 2020| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −91.5% | Jan 2021 | Oct 2023 | Not yet | 5.8 years so far |
| −35.9% | Dec 2020 | Jan 2021 | Jan 2021 | 1 month |
| −34.5% | Sep 2020 | Nov 2020 | Nov 2020 | 2 months |
| −23.2% | Aug 2020 | Aug 2020 | Sep 2020 | 3 weeks |
| −18.1% | Sep 2020 | Sep 2020 | Sep 2020 | 2 weeks |